• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮经肝门静脉-腔静脉聚四氟乙烯涂层分流术术后 2 天内肝素化后早期血栓的回顾性评估。

Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization.

机构信息

Department of Diagnostic and Interventional Radiology, University of Leipzig Medical Center, Leipzig, Germany.

Department of Radiology, University Hospital Regensburg, 93042, Regensburg, Germany.

出版信息

Sci Rep. 2022 Jun 22;12(1):10506. doi: 10.1038/s41598-022-14388-3.

DOI:10.1038/s41598-022-14388-3
PMID:35732875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217914/
Abstract

The development of acute thrombosis within the TIPS tract may be prevented by prophylactic anticoagulation; however, there is no evidence of the correct anticoagulation regimen after TIPS placement. The purpose of this single-center retrospective study was to evaluate the short-term occlusion rate of transjugular intrahepatic portosystemic shunts (TIPSs) with polytetrafluorethylene (PTFE)-coated stents under consequent periprocedural full heparinization (target partial thromboplastin time [PTT]: 60-80 s). We analyzed TIPS placements that were followed up over a six-month period by Doppler ultrasound in 94 patients and compared the study group of 54 patients who received intravenous periprocedural full heparinization (target PTT: 60-80 s) without any other anticoagulation to patients with prolonged anticoagulation medication. The primary endpoint was TIPS patency after six months. The primary patency rate was 88.3% overall, and in the study group, 90.7%, with an early thrombosis rate of 3.2% (study group: 1.9%) and a primary assisted patency rate of 95.7% (study group: 96.3%). In the study group, one case of TIPS thrombosis occurred on the 23rd day after TIPS placement. Two patients underwent reintervention because of stenosis or buckling. Moreover, the target PTT was not attained in 8 of the 54 patent TIPSs. Four patients had an increased portosystemic pressure gradient, without stenosis, and the flow rate was corrected by increasing the TIPS diameter by dilation. Two-day heparinization seems sufficient to avoid early TIPS thrombosis over a six-month period.

摘要

经颈静脉肝内门体分流术(TIPS)腔内预防性抗凝可预防急性血栓形成;然而,TIPS 术后正确的抗凝方案尚无定论。本单中心回顾性研究旨在评估聚四氟乙烯(PTFE)涂层支架 TIPS 术后在连续围手术期充分肝素化(目标部分凝血活酶时间[PTT]:60-80s)下的短期闭塞率。我们分析了 94 例患者在 6 个月的时间内通过多普勒超声进行随访的 TIPS 放置情况,并将接受围手术期静脉内充分肝素化(目标 PTT:60-80s)且无其他抗凝治疗的 54 例患者作为研究组与延长抗凝药物治疗的患者进行比较。主要终点是 6 个月后的 TIPS 通畅率。总体主要通畅率为 88.3%,研究组为 90.7%,早期血栓形成率为 3.2%(研究组:1.9%),主要辅助通畅率为 95.7%(研究组:96.3%)。在研究组中,1 例患者在 TIPS 放置后第 23 天发生 TIPS 血栓形成。2 例患者因狭窄或卷曲而行再次介入治疗。此外,在 54 例通畅的 TIPS 中,有 8 例未达到目标 PTT。4 例患者出现门体压力梯度增高,但无狭窄,通过扩张增加 TIPS 直径纠正了血流率。2 天的肝素化似乎足以在 6 个月内避免早期 TIPS 血栓形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/b11aa73b0111/41598_2022_14388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/2776cf5b728d/41598_2022_14388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/128200b62f4d/41598_2022_14388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/ceaa35dff31b/41598_2022_14388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/c3198bbd96af/41598_2022_14388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/b11aa73b0111/41598_2022_14388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/2776cf5b728d/41598_2022_14388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/128200b62f4d/41598_2022_14388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/ceaa35dff31b/41598_2022_14388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/c3198bbd96af/41598_2022_14388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb4/9217914/b11aa73b0111/41598_2022_14388_Fig5_HTML.jpg

相似文献

1
Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization.经皮经肝门静脉-腔静脉聚四氟乙烯涂层分流术术后 2 天内肝素化后早期血栓的回顾性评估。
Sci Rep. 2022 Jun 22;12(1):10506. doi: 10.1038/s41598-022-14388-3.
2
Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.用于经颈静脉肝内门体分流术创建的Viatorr膨体聚四氟乙烯覆膜支架移植物的回顾性多中心试验结果。
J Vasc Interv Radiol. 2004 Nov;15(11):1219-30. doi: 10.1097/01.RVI.0000137434.19522.E5.
3
Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.经 Fluent 支架型分流器经颈静脉肝内门体分流术治疗的静脉曲张出血患者的分流功能障碍和总体生存的预测因素。
Acad Radiol. 2018 Jul;25(7):925-934. doi: 10.1016/j.acra.2017.11.020. Epub 2018 Jan 17.
4
Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts.经颈静脉肝内门体分流术在人体中的通畅性改善:使用聚四氟乙烯覆膜支架进行创建和修复。
Radiology. 1999 Dec;213(3):759-66. doi: 10.1148/radiology.213.3.r99dc28759.
5
Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.经颈静脉肝内门体分流术治疗患者中聚四氟乙烯覆膜支架的通畅性:一项随机多中心研究的长期结果
Liver Int. 2007 Aug;27(6):742-7. doi: 10.1111/j.1478-3231.2007.01522.x.
6
Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.聚四氟乙烯覆膜支架移植物与裸支架治疗经颈静脉肝内门体分流术功能障碍的比较
Eur J Radiol. 2005 Jul;55(1):120-4. doi: 10.1016/j.ejrad.2004.10.007.
7
Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.用于经颈静脉肝内门体分流术的膨体聚四氟乙烯覆膜支架移植物的早期和长期临床及影像学随访结果
Eur Radiol. 2004 Oct;14(10):1842-50. doi: 10.1007/s00330-004-2359-4. Epub 2004 Jun 25.
8
Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?揭开覆膜支架的真相:经颈静脉肝内门体分流术的覆膜支架与非覆膜支架有区别吗?
Am J Surg. 2011 Nov;202(5):561-4. doi: 10.1016/j.amjsurg.2011.06.021. Epub 2011 Sep 23.
9
Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.经皮经肝球囊辅助经颈静脉肝内门体分流术治疗慢性、完全闭塞性门静脉血栓形成伴症状性门静脉高压:操作技术、安全性和临床应用。
Eur Radiol. 2015 Dec;25(12):3431-7. doi: 10.1007/s00330-015-3777-1. Epub 2015 Apr 23.
10
Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device.裸金属支架与聚四氟乙烯覆膜支架型装置行经颈静脉肝内门体分流术的技术及临床结果比较
Cardiovasc Intervent Radiol. 2016 Apr;39(4):547-56. doi: 10.1007/s00270-015-1209-x. Epub 2015 Sep 24.

引用本文的文献

1
Possibility of modern ultrasound imaging of portal venous system.门静脉系统现代超声成像的可能性。
Clin Hemorheol Microcirc. 2025 May;90(1):3-13. doi: 10.1177/13860291251324086. Epub 2025 Jun 2.

本文引用的文献

1
Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals.肝硬化患者经颈静脉肝内门体分流术:对德国43家医院适应证、操作标准化及抗凝情况的调查评估
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1179-1185. doi: 10.1097/MEG.0000000000001628.
2
Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft.经覆膜支架的经颈静脉肝内门体分流术(TIPS)的长期随访。
Diagn Interv Radiol. 2019 Sep;25(5):346-352. doi: 10.5152/dir.2019.18416.
3
[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].
[更新的S2k指南“肝硬化并发症”。德国胃肠病学会(DGVS)]
Z Gastroenterol. 2019 May;57(5):611-680. doi: 10.1055/a-0873-4658. Epub 2019 May 6.
4
Anticoagulation Therapy in Patients with Liver Cirrhosis is Associated With an Increased Risk of Variceal Hemorrhage.肝硬化患者的抗凝治疗与静脉曲张出血风险增加相关。
Am J Med. 2019 Jun;132(6):758-766. doi: 10.1016/j.amjmed.2019.01.006. Epub 2019 Jan 18.
5
Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation.经颈静脉肝内门体分流术创建后支架移植物血栓形成的危险因素。
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S150-S158. doi: 10.21037/cdt.2017.10.03.
6
Anticoagulation in cirrhosis: a new paradigm?肝硬化中的抗凝治疗:一种新的模式?
Clin Mol Hepatol. 2017 Mar;23(1):13-21. doi: 10.3350/cmh.2016.0110. Epub 2017 Mar 14.
7
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.阿哌沙班可减少静脉血栓栓塞患者的住院率:阿哌沙班用于肺栓塞和深静脉血栓形成初始治疗作为一线疗法的分析(AMPLIFY)试验
J Am Heart Assoc. 2015 Dec 1;4(12):e002340. doi: 10.1161/JAHA.115.002340.
8
Transjugular intrahepatic portosystemic shunt complications: prevention and management.经颈静脉肝内门体分流术并发症:预防与处理
Semin Intervent Radiol. 2015 Jun;32(2):123-32. doi: 10.1055/s-0035-1549376.
9
TIPS geometry influences patency.经颈静脉肝内门体分流术的几何形状影响通畅性。
Z Gastroenterol. 2015 Jan;53(1):28-32. doi: 10.1055/s-0034-1385430. Epub 2015 Jan 16.
10
Stratifying the risks of oral anticoagulation in patients with liver disease.对肝病患者口服抗凝治疗的风险进行分层。
Circ Cardiovasc Qual Outcomes. 2014 May;7(3):461-7. doi: 10.1161/CIRCOUTCOMES.113.000817. Epub 2014 May 13.